Mesothelioma Science News October 15, 2008

Mesothelioma Science News
San Pedro, CA - October 15, 2008

Chemotherapy
Assessment of survival and clinical benefit in malignant pleural mesothelioma patients treated with gemcitabine and carboplatin  Click here

Diagnosis/staging
CK5/6 in effusions: no difference between mesothelioma and pulmonary and nonpulmonary adenocarcinoma  Click here
 
Increased 8-isoprostane, a marker of oxidative stress in exhaled breath condensate in subjects with asbestos exposure  Click here

Pulmonary epithelioid hemangioendothelioma mimicking mesothelioma  Click here

Peritoneal mesothelioma
Peritoneal Mesothelioma  Click here

Risk factors
Pooled analysis of NAT2 genotypes as risk factors for asbestos-related malignant mesothelioma  Click here

Health Effects of Nanoparticles and Nanomaterials (III)  Click here

Tumor suppression
Functional inactivation of NF2/merlin in human mesothelioma

Discussions

Review and discussion of tumor stage as a prognostic factor for the outcome of surgery for mesothelioma and its implications for whether or not a patient is a candidate for surgery  Click here

Review and discussion of "Open lung-sparing surgery for malignant pleural mesothelioma: the benefits of a radical approach within multimodal therapy" by Apostolos Nakas et al., European Journal of Cardio-thoracic Surgery, 2008  Click here